Gerald Lelais

Gerald Lelais is an experienced professional in the field of chemistry and drug development, currently serving as Executive Director at Odyssey Therapeutics since November 2021. Prior to this role, Gerald held multiple positions at GNF from October 2006 to December 2021, including Associate Director and Senior Research Investigator, focusing on Hit-to-Lead and Lead Optimization processes for various GPCR and kinase projects. Gerald's academic credentials include a Postdoctoral Research Fellowship in Chemistry from Caltech and a Ph.D. in Chemistry, along with a B.S. in Chemistry from ETH Zürich.